Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Inflamm Res ; 64(3-4): 171-83, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25596950

RESUMO

OBJECTIVES: To investigate Toll-like receptor activation in human skin using tape stripping and imiquimod cream challenges in healthy volunteers. SUBJECTS, TREATMENT AND METHODS: Seventeen male Caucasian subjects underwent a baseline biopsy on their lower back prior to two tape stripping procedures 7 days apart. Subjects were then treated with 5% imiquimod for 2 and 4 days on separate sites in the same area. Further biopsies were taken 22-24 h after each challenge and mRNA and microRNA extracted and expression values analysed using robust statistical and pathway analysis methods. RESULTS: Fifteen of the 17 subjects completed the study according to protocol. No adverse events were associated with the procedures. A significant change (p < 0.05, fold change >1.5 or <-1.5) in mRNA expression of 7,996 genes was evident in biopsies taken at both time points post tape stripping, compared to baseline biopsy expression values. The induction of mRNAs involved in various pathways including adhesion and migration was evident. mRNA markers representing inflammatory cells [e.g., CD14, CD3E (p < 0.0001)] and mRNAs encoding genes regulated by type 1 interferon (IFN) [e.g., MX1, OAS1and CXCL10 (p < 0.0001)] were significantly up-regulated. IFNα and CXCL10 proteins were detectable in exudates released 1 and 4 h post tape stripping. A putative signalling network associating these transcripts and six microRNAs (hsa-miR, -31, -132, -155, 548c, 548n and 574) was identified using a meta-regulation network model. microRNAs not previously associated with IFN signalling have been identified. In contrast, only 223 known transcripts were significantly changed after imiquimod treatment, including CXCL10, and OAS1. CONCLUSION: Results suggest that IFN signalling is important in these translational models and novel miRNA may be new targets in the treatment of IFN associated skin disease.


Assuntos
Dermatite/tratamento farmacológico , Dermatite/metabolismo , Descoberta de Drogas/métodos , Interferon Tipo I/genética , Interferon Tipo I/metabolismo , Processamento de Proteína Pós-Traducional/genética , 2',5'-Oligoadenilato Sintetase/genética , 2',5'-Oligoadenilato Sintetase/metabolismo , Adolescente , Adulto , Aminoquinolinas/administração & dosagem , Aminoquinolinas/efeitos adversos , Biópsia , Quimiocina CXCL10/genética , Quimiocina CXCL10/metabolismo , Dermatite/etiologia , Humanos , Imiquimode , Masculino , MicroRNAs/genética , MicroRNAs/metabolismo , Pessoa de Meia-Idade , Modelos Genéticos , Transdução de Sinais/genética , Transdução de Sinais/fisiologia , Pele/metabolismo , Pele/patologia , Creme para a Pele/efeitos adversos , Fita Cirúrgica/efeitos adversos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...